262.2 ð åèç
262.2.0.1 å¿ è â Cardiac CT
262.2.0.2 å¿ è â Cardiac MRI Indications
- Cardiomyopathy (DCM, HCM, RCM, ARVC, amyloid, sarcoid, Fabry, hemochromatosis)
- Myocarditis (Lake Louise criteria)
- Viability assessment (LGE > 50% = non-viable)
- Congenital heart disease
- Cardiac masses
- Pericardial disease
262.2.0.3 å¿ è â LGE Patterns
| Pattern | Disease |
|---|---|
| Subendocardial CAD-distribution | Infarction |
| Mid-wall septal/lateral | DCM |
| Patchy mid-wall | Sarcoidosis |
| Epicardial / subepicardial | Myocarditis |
| Subendocardial circumferential + atrial + RV | Amyloidosis |
| Septal junction | HCM |
| Sub-tricuspid (free wall) | ARVC |
262.2.0.4 å¿ è â Nuclear Cardiology
- SPECT: stress + rest perfusion; reversible (ischemia) vs fixed (scar) defects
- PET: higher resolution + coronary flow reserve; better for obese
- FDG-PET: cardiac sarcoidosis (active inflammation)
- PYP / HMDP: ATTR amyloidosis (sensitive + specific with negative FLC)
262.2.0.5 å¿ è â Viability Assessment
- FDG-PET mismatch (perfusion â + FDG uptake â) = hibernating myocardium (will recover with revascularization)
- Cardiac MRI: LGE > 50% wall thickness = non-viable
262.2.0.6 å¿ è â Stress Imaging Selection
- Stress echo: canât exercise; intermediate-high pretest probability
- Stress MPI / PET: similar; particularly for obese / specific clinical questions
- Stress MRI: specific scenarios; no radiation